CPT code 38210: T-cell depletion, harvest processing2026 Medicare rate & RVUs in Massachusetts
Reports processing a harvested stem cell product to reduce T cells; Medicare requires a different code for reporting and payment.
CMS doesn’t publish an office rate for 38210 in Massachusetts.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What 38210 covers
Code 38210 identifies processing of a harvested hematopoietic stem cell product to reduce its T-cell content. The processing targets T cells in the collected product; it is distinct from collecting stem cells. It also differs from processing directed at tumor cells, red blood cells, platelets, or product volume, and from concentrating harvested stem cells. Collection codes describe obtaining cells, while 38210 identifies a manipulation of the harvested product. Bone marrow aspiration and biopsy codes describe diagnostic procedures, not this harvest-processing service.
Medicare assigns CPT 38210 status I, meaning the code is not valid for Medicare; Medicare uses a different code to report and pay for this service. For Medicare reporting, use the applicable code for the processing service rather than 38210.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where 38210 pays more and less in Massachusetts
| Payment locality | Office | Facility |
|---|---|---|
| Metropolitan Boston, MA | Unavailable | Unavailable |
| Rest of Massachusetts | Unavailable | Unavailable |
How the 38210 rate is calculated
Each of 38210’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · 38210
RVUs × geographic indexes × conversion factor
Work1.53
1.53 RVUs× 1.000 GPCI
Practice expense0.34
0.34 RVUs× 1.000 GPCI
Malpractice0.16
0.16 RVUs× 1.000 GPCI
Adjusted RVUs
2.0300
Conversion factor
$33.4009
Medicare rate
$67.80
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for 38210
38210 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · 38210
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
38210 isn’t priced in this setting.
38210 compared with similar codes
Compare codes · National
5 codes, side by side
How to choose
- 38211Tumor-cell depletionStem cell harvest processing
- Choose 38211 for tumor-cell depletion. Code 38210 concerns removing T cells from the harvested product.
- 38212RBC depletionStem-cell harvest
- Code 38212 concerns red-cell depletion, not T-cell depletion.
- 38213Platelet depletionStem cell harvest processing
- Code 38213 concerns platelet depletion. The distinction is the component removed from the harvest.
- 38205Stem cell collectionAllogeneic, blood-derived
- Code 38205 describes allogeneic stem cell collection. Code 38210 describes processing a harvest to reduce T cells.
38210 billing questions
What does T-cell depletion distinguish from tumor-cell depletion?
T-cell depletion reduces T cells in the harvested product. Code 38211 describes tumor-cell depletion instead.
Is 38210 the Medicare code for this processing?
No. Medicare status I means 38210 is not valid for Medicare; Medicare uses a different code to report and pay for the service.
Does 38210 describe stem cell collection?
No. It describes processing a harvested product to reduce T cells. Codes 38205 and 38206 describe allogeneic and autologous stem cell harvesting, respectively.
How does this differ from red-cell or platelet depletion?
The target of processing differs: 38212 concerns red-cell depletion, while 38213 concerns platelet depletion. T-cell depletion targets T cells in the harvest.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put 38210 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist